Acceleron Pharma

Acquired

Merck | Home

Cambridge, United States · Founded 2003 · $65.5M raised

Employees
201–500
Founded
2003
Business Model
B2B
Total Funding
$65.5M
Last Round
$25.0M Corporate RoundFeb 2011
Rounds
4
Acquired by
Merck & Co.Sep 2021 · $11.5B

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Acceleron Pharma was a Cambridge, Massachusetts-based biopharmaceutical company focused on the discovery and development of transformative therapies that regulate the TGF-β superfamily of proteins. Its lead asset, sotatercept, was a first-in-class activin receptor fusion protein for pulmonary arterial hypertension. Founded in 2003, the company went public in September 2013 on NASDAQ (XLRN) and had approximately 312 employees at the time of its acquisition. Merck acquired Acceleron in November 2021 for $11.5 billion.

Summary

Acceleron Pharma is a Biotech company based in Cambridge, United States, founded in 2003. It has raised $65.5M in total across 4 rounds, most recently a $25.0M Corporate Round in Feb 2011. Investors include Merck Life Sciences, Polaris Partners and Advanced Technology Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionSep 2021

Sign up to see all 6 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Acceleron Pharma on Indexed.vc
<a href="https://indexed.vc/companies/acceleron-pharma"><img src="https://indexed.vc/api/badge/company/acceleron-pharma" alt="Acceleron Pharma on Indexed.vc" width="260" height="76" /></a>